Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT05990725 · COMPLETED
Trial details
- NCT number
- NCT05990725
- Sponsor
- Almirall, S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2025-06-25
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.